Mediplantex National Pharmaceutical JSC (HNX:MED)
Vietnam flag Vietnam · Delayed Price · Currency is VND
20,400
0.00 (0.00%)
At close: Jan 30, 2026

HNX:MED Cash Flow Statement

Millions VND. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Jan '24 Dec '22 Dec '21
Net Income
15,27215,24711,7446,3663,747
Depreciation & Amortization
7,3147,9168,44410,0209,536
Other Amortization
7.43----
Loss (Gain) From Sale of Assets
--773.89-6,395-3,782-3,902
Other Operating Activities
1,9112,015-1,9361,683-2,016
Change in Accounts Receivable
27,98123,26137,5082,06358,829
Change in Inventory
-5,15715,425-1,583-14,6644,843
Change in Accounts Payable
-62,339-16,803-95,35126,049-6,766
Change in Other Net Operating Assets
-261.581,3683,660-1,503-2,160
Operating Cash Flow
-15,27247,653-43,90826,23162,110
Operating Cash Flow Growth
----57.77%-30.49%
Capital Expenditures
-4,881-9,979-40,594-117,270-54,364
Sale of Property, Plant & Equipment
--43.64240.21992.27
Investment in Securities
5,3008,00072,400-44,0006,000
Other Investing Activities
500.991,1217,2043,3543,479
Investing Cash Flow
919.91-858.4239,054-157,676-43,893
Short-Term Debt Issued
133,282157,753193,594205,142180,305
Total Debt Issued
133,282157,753193,594205,142180,305
Short-Term Debt Repaid
-127,155-194,430-219,966-182,973-192,316
Total Debt Repaid
-127,155-194,430-219,966-182,973-192,316
Net Debt Issued (Repaid)
6,127-36,676-26,37222,168-12,012
Issuance of Common Stock
---153,104-
Common Dividends Paid
-9,985-11,021-6,426-8,816-13,281
Financing Cash Flow
-3,858-47,697-32,799166,456-25,293
Foreign Exchange Rate Adjustments
--19.532.9-28.96-
Net Cash Flow
-18,210-922.47-37,65034,983-7,076
Free Cash Flow
-20,15337,674-84,502-91,0397,746
Free Cash Flow Growth
-----87.20%
Free Cash Flow Margin
-5.49%8.50%-20.98%-22.70%2.25%
Free Cash Flow Per Share
-1624.483035.74-6809.19-9696.321234.13
Cash Interest Paid
2,3053,8165,4324,9533,643
Cash Income Tax Paid
3,3993,8744,719272.582,383
Levered Free Cash Flow
-13,44529,827-101,170-115,88114,442
Unlevered Free Cash Flow
-12,05932,195-97,798-112,75416,703
Change in Working Capital
-39,77723,250-55,76511,94554,746
Source: S&P Global Market Intelligence. Standard template. Financial Sources.